Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
sansure.com.cn

See what CB Insights has to offer

Stage

IPO | IPO

Total Raised

$77M

Date of IPO

8/28/2020

About Sansure Biotech

Sansure Biotech (688289.SH) focuses on molecular diagnosis and genetic testing techniques. The company provides innovative molecular diagnosis and genetic testing kits and tools to diagnostic labs and researchers.

Sansure Biotech Headquarter Location

No.680, Lusong Road, Hi-Tech Development Zone Yuelu District, Hunan Province

Changsha, Hunan, 410205,

China

+86 0731-88883176

Latest Sansure Biotech News

Sansure Biotech’s IPO debut on SSE STAR Market today - ChinaKnowledge

Aug 28, 2020

Sansure Biotech’s IPO debut on SSE STAR Market today CKN 2,725 Aug 28, 2020 (China Knowledge) - Sansure Biotech (688289) to start trading on the Shanghai STAR Market today, at a public offering price of RMB 50.48 per share, raising RMB 2.02 bln. Its initial listing shares account for 10% of total outstanding shares. The company’s initial price-to-earning ratio (PE) stands at 536.3. CITIC Securities, Western Securities acted as the lead underwriter, and Western Securities served as the sponsor fo

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sansure Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sansure Biotech is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

C

China Digital Health Collection

467 items

M

Medical Devices

7,401 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

H

Health & Wellness Assessment

2,359 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

I

Infectious Disease

2,222 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

O

Omics

1,025 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Sansure Biotech Patents

Sansure Biotech has filed 2 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/26/2016

3/30/2021

Molecular biology, Drug delivery devices, Biotechnology, Dosage forms, Molecular biology techniques

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/26/2016

00/00/0000

Grant Date

3/30/2021

00/00/0000

Title

Subscribe to see more

Related Topics

Molecular biology, Drug delivery devices, Biotechnology, Dosage forms, Molecular biology techniques

Subscribe to see more

Status

Grant

Subscribe to see more

Sansure Biotech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sansure Biotech Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.